Skip to main content
Army Medicine Home Army Medicine Home


Anthrax Vaccination Program (1998)

The Department of Defense's Anthrax Vaccine Immunization Program began in March 1998. Implementation slowed in July 2000 due to an unanticipated delay in release of FDA-approved vaccine. Implementation resumed in June 2002, expanding to support Operations Iraqi Freedom and Enduring Freedom. The AVIP is currently paused, due to a judicial injunction, to allow for a 90-day comment period on a proposed order by the Food and Drug Administration.

The program is conducted consistent with U.S. Food and Drug Administration-approved labeling and the best practice of medicine. DOD policy is to immunize those military personnel, emergency-essential DOD civilians and contractor personnel who are assigned or deployed for more than 15 days to higher threat areas, and whose performance is essential for certain mission-critical capabilities.

America's best scientists reviewed in detail the science underlying the effectiveness and safety of anthrax vaccine, including 18 human safety studies. These expert scientists agree that anthrax vaccine protects and is as safe as other vaccines.

For more details, visit the Anthrax Vaccine Immunization Program. External link (opens new browser window)